Tuberculosis control has failed in South Africa - time to reappraise strategy

South African Medical Journal

Volumn 101, Issue 2, 2011, Pages 111-114

  Wood, Robin ^a,b   Lawn, Stephen D ^a,c   Johnstone Robertson, Simon ^a,b   Bekker, Linda Gail ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ARTICLE; BACTERIAL TRANSMISSION; CASE FINDING; CASE MANAGEMENT; EPIDEMIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; OUTCOME ASSESSMENT; PREVALENCE; SCREENING; SECONDARY INFECTION; SOUTH AFRICA; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 79551718362     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/samj.4587     Document Type: Article

References (40)

1. World Health Organization. Global Tuberculosis Control. A Short Update to the 2009 Report. Report No. WHO/HTM/TB/2009.426. Geneva: World Health Organization, 2009.
2. World Health Organization. Global Tuberculosis Control 2009. Epidemiology, Strategy, Financing. Report No: WHO/HTM/TB/2009.411. Geneva: World Health Organization, 2009.
3. Kaplan R, Bekker L-G, Caldwell J, et al. HIV prevalence, CD4 count distribution and case fatality for TB patients treated in primary health care facilities in Cape Town. Abstracts of the 2nd South African TB Conference. Durban, South Africa. May 2010. Abstract #306. 2010.
4. Reider HL. Epidemiological basis of tuberculosis control. Paris: International Union against Tuberculosis and Lung Disease, 1999.
5. van Rie A, Beyers N, Gie RP, Kunneke M, Zietsman L, Donald PR. Childhood tuberculosis in an urban population in South Africa: burden and risk factor. Arch Dis Child 1999;80:433-437.
6. Sutherland I. The ten-year incidence of clinical tuberculosis following "conversion" in 2550 individuals aged 14 to 19 years. The Hague, The Netherlands: TSRU Progress Report; KNCV, 1968.
7. Shanaube1 K, Sismanidis C, Ayles H, et al. Annual risk of tuberculous infection using different methods in communities with a high prevalence of TB and HIV in Zambia and South Africa. PlosOne 2009; 4(11) e7749.
8. Middelkoop K, Bekker LG, Myer L, Dawson R, Wood R. Rates of tuberculosis transmission to children and adolescents in a community with a high prevalence of HIV infection among adults. Clin Infect Dis 2008;47:349-355.
9. Wood R, Hua Liang, Lawn SL, Middelkoop K, Wilkinson R, Hulin Wu. Prevalence of latent mycobacterium tuberculosis infection in adolescents and young adults in Cape Town, South Africa. Int J Tuberc Lung Dis 2010;14(4):406-412.
10. Kritzinger FE, Den Boon S, Verver S, et al. No decrease in annual risk of tuberculosis infection in endemic area in Cape Town, South Africa. Trop Med Int Health 2009;14(2):136-142.
11. Wood R, Middelkoop K, Myer L, et al. Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. Am J Respir Crit Care Med 2007;175:87-93.
12. Middelkoop K, Bekker L-G, Myer L, et al. Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South African township Am J Respir Crit Care Med 2010; 25 June (epub ahead of print).
13. Vynnycky E, Fine PEM. Interpreting the decline in tuberculosis: the role of secular trends in effective contact. Int J Epidemiol 1999;28:327-334.
14. Abbey H. An examination of the Reed-Frost theory of epidemics. Hum Biol 1952;24:201-233.
15. Bekker L-G, Orrell C, Reader L, et al. Antiretroviral therapy in a community clinic: Early lessons from a pilot project. S Afr Med J 2003;93(6):458-462.
16. Holmes CB, Wood R, Badri M, et al. CD4 decline and incidence of opportunistic infections in Cape Town, South Africa. Implications for prophylaxis and treatment. JAIDS 2006:42(4):464-469.
17. Selwyn PA, Alcabes P, Hartel D, et al. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med 1992;327(24):1697-1703.
18. Rieder HL, Cauthen GM, Bloch AB, et al Tuberculosis and acquired immunodeficiency syndrome- Florida. Arch Intern Med 1989;149:1268-1273.
19. Center for Disease Control. Tuberculosis and acquired immunodeficiency syndrome-New York City. Morb Mortal Wkly Rep 1987;35:785-796.
20. Di Perri G, Cruciani M, Danzi MC, et al. Nosochomial epidemic of active tuberculosis among HIVinfected patients. Lancet 1989;2:1502-1504.
21. Edlin BR, Tokars JI, Grieco HM, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with acquired immunodeficiency syndrome. N Engl J Med 1992;326:1514-1521.
22. Lawn SD, Myer L, Bekker L-G, Wood R. Burden of tuberculosis in a South African antiretroviral treatment (ART) service: impact on ART outcomes and implications for TB control. AIDS 2006;20(12):1605-1612.
23. Lawn SL, Myer L, Edwards D, Bekker L-G, Wood R. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS 2009;23(13):1717-1725.
24. Lawn SD, Wood R, De Cock KM, Kranzer K, Lewis J, Churchyard G. Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in resource-constrained settings. Lancet Infect Dis 2010;10:489-498.
25. Golub JE, Mohan CI, Comstock GW, Chaisson RE. Active case finding of tuberculosis: historical perspective and future prospects Int J Tuberc Lung Dis 9(11):1183-1203.
26. Kranzer K, Houben R, Glynn JR, Bekker LG, Wood R, Lawn SD. Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: systematic review and meta-analysis. Lancet Infect Dis 2010;10:93-102.
27. Lawn SD, Kranzer K, Edwards DJ, McNally M, Bekker LG, Wood R. Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pre-treatment screening strategy. AIDS 2010;24:1323-1328.
28. Bassett IV, Wang B, Chetty S, et al. Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis 2010;51(7):823-829.
29. World Health Organization. WHO Position Paper on BCG Vaccination. Wkly Epidemiol Rec 2004;79:25-40.
30. World Health Organization. The Stop TB Strategy: building on enhancing DOTS to meet the TB related Millenium Development Goals. Report No: WHO/HTM/TB/2006.368. Geneva: World Health Organization, 2006.
31. World Health Organization. The Global Plan to Stop TB, 2006-2015: actions for life towards a world free of tuberculosis. Report No: WHO/STB/2006.35. Geneva: World Health Organization, 2006.
32. Styblo K. Impact of HIV infection on the tuberculosis problem worldwide. Kekkaku 1990;65:429-438.
33. De Cock KM, Chaisson RE. Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection. Int J Tuberc Lung Dis 1999;3:457-465.
34. Becerra MC, Pacheo-Torreblanca IF, Boyona J, et al. Expanding tuberculosis case detection by screening household contacts. Public Health Rep 2005;120:271-277.
35. Corbett EL, Bandason T, Duong T, et al. Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial. Lancet 2010; (epub ahead of print).
36. Samandari T. Preliminary results of the Botswana isoniazid preventive therapy (IPT) clinical trial. 40th Union World Conference on Lung Health. Cancun, Mexico: Dec. 3 - 7 2009.
37. Golub JE, Pronyk P, Mohapi L, et al. Isoniazid preventive therapy, HAART and tuberculosis risk in HIVinfected adults in South Africa: a prospective cohort. AIDS 2009;23(5):631-666.
38. Montaner JSG, Hogg R, Wood E, et al. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 2006;368:531-536.
39. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009;373:48-57.
40. Lawn SD, Anthony D, Harries AD, et al. Will ART do it? Antiretroviral therapy for control of HIVassociated tuberculosis. Int J Tuberc Lung Dis 2010 (in press).